Terms: = Kidney tumors AND XPO1, DKFZp686B1823, 7514, ENSG00000082898, O14980, CRM1 AND Treatment
6 results:
1. [A rational analysis of the commonly used renal tumor scoring systems in predicting surgical outcomes of cystic renal masses].
Chen W; Wang YL; Cheng K; Chen BH; Zhang P; Fang QX; Wu DP
Zhonghua Yi Xue Za Zhi; 2023 Nov; 103(42):3424-3430. PubMed ID: 37587681
[No Abstract] [Full Text] [Related]
2. Selinexor demonstrates anti-tumor efficacy in paired patient-derived xenograft models and hydrogel-embedded histoculture drug sensitivity test of penile cancer.
He Y; Mei J; Hao H; Liu F; Yi Y; Hu C; Zou F; Lu X
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6931-6941. PubMed ID: 36840755
[TBL] [Abstract] [Full Text] [Related]
3. Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors.
Coutinho DF; Mundi PS; Marks LJ; Burke C; Ortiz MV; Diolaiti D; Bird L; Vallance KL; Ibáñez G; You D; Long M; Rosales N; Grunn A; Ndengu A; Siddiquee A; Gaviria ES; Rainey AR; Fazlollahi L; Hosoi H; Califano A; Kung AL; Dela Cruz FS
Med; 2022 Nov; 3(11):774-791.e7. PubMed ID: 36195086
[TBL] [Abstract] [Full Text] [Related]
4. Specific inhibition of the nuclear exporter exportin-1 attenuates kidney cancer growth.
Wettersten HI; Landesman Y; Friedlander S; Shacham S; Kauffman M; Weiss RH
PLoS One; 2014; 9(12):e113867. PubMed ID: 25461627
[TBL] [Abstract] [Full Text] [Related]
5. crm1 blockade by selective inhibitors of nuclear export attenuates kidney cancer growth.
Inoue H; Kauffman M; Shacham S; Landesman Y; Yang J; Evans CP; Weiss RH
J Urol; 2013 Jun; 189(6):2317-26. PubMed ID: 23079374
[TBL] [Abstract] [Full Text] [Related]
6. [Collecting duct renal cell carcinoma].
Husillos A; Herranz-Amo F; Subirá D; Lledó E; Molina-Escudero R; Hernández-Fernández C
Actas Urol Esp; 2011 Jun; 35(6):368-71. PubMed ID: 21450372
[TBL] [Abstract] [Full Text] [Related]